about
Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammationBronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosaPseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.Effect of dynamic random leaks on the monitoring accuracy of home mechanical ventilators: a bench study.The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patientsFunctional Metagenomics of the Bronchial Microbiome in COPD.C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severityOmalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study.Reply to "chronic obstructive pulmonary disease lung microbiota diversity may be mediated by age or inhaled corticosteroid use".[Respiratory day hospital: Impact on the rate of hospital admissions due to chronic obstructive pulmonary disease exacerbations].[Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test in chronic obstructive pulmonary disease with severe airflow limitation].Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter Study.A step-down protocol for omalizumab treatment in oral corticosteroid-dependent allergic asthma patients.[Current treatment of chronic obstructive pulmonary disease].Roflumilast added to triple therapy in patients with severe COPD: a real life study.Influence of dynamic leaks in volume-targeted pressure support noninvasive ventilation: a bench study.Noninvasive mechanical ventilation. Reflections on home monitoring.Non-invasive home mechanical ventilation: effectiveness and efficiency of an outpatient initiation protocol compared with the standard in-hospital model[Yellow nails syndrome as a form of presentation of pleural effusion][Urinothorax: always a transdative pleural effusion?]Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients[Causes of death and risk factors for mortality in patients with severe chronic obstructive pulmonary disease][Respiratory day hospital: what have we learned?]Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To Pseudomonas aeruginosa: A Retrospective Cohort Study
P50
Q28071694-EA4671D3-4F95-4C98-8B90-F67F405932D5Q33701145-E8BCF75A-956C-4F2C-AFC0-B5F038741105Q33889496-AA51D1A2-4C4B-4310-B7B8-2C40CEA99BCCQ35036214-B33EFB34-58DA-49D4-BC14-C64909F47916Q35064454-6C168B26-DFD1-4F0E-BC4B-C69505EAC4FEQ36254351-A7478561-2AAE-4EE5-BBE4-30F3F66B29D5Q36345407-F4FF7213-1C45-4742-9B30-24108F2134D9Q40472843-32D8CB98-11EF-4B26-A83E-937054344C9AQ42293331-8B8B6600-A5AC-4C6F-A186-E0868E07836EQ43224993-EBE25A86-15B5-497F-86E6-5CD386A95DEAQ43934252-B5C3A7C9-5E29-4A9B-BCFC-9BB0E965736BQ44652193-2EC87963-8454-491D-9423-36F355D771DFQ47879585-A9310ADE-3CDC-4EA9-98FC-B9D0A41703A1Q48169301-FDAEB891-F65A-47AF-AE43-D289E08D70E0Q50249521-63D603F2-825C-4FCC-AC6E-A8F11AA24130Q50456357-04B5ECF6-F02E-45F4-9047-60A84B293C22Q50458428-A9F1F31E-1567-4CE3-8104-7561D2EFD74CQ51122249-777631F7-4B1F-45DD-B8D4-1A440CBA84E1Q79450724-687046A8-E95D-4585-BE30-BEC697917D77Q80069520-754B8C5F-34CE-4976-98CE-A44CA4867B0DQ81190728-930DB626-135F-404C-ABF3-148CE9808737Q82483360-3FC12F86-6861-4247-8C29-7A3F4FADA8DCQ83574405-B819B89B-E469-46C4-B7A5-3998FBAB40BEQ84697340-7520632E-480A-4B43-92FE-4C50FC7E8B5CQ91705436-7100EE75-FCFA-4316-B117-17AFCA9EB669
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Xavier Pomares
@en
Xavier Pomares
@nl
type
label
Xavier Pomares
@en
Xavier Pomares
@nl
prefLabel
Xavier Pomares
@en
Xavier Pomares
@nl
P31
P496
0000-0002-2783-414X